96 related articles for article (PubMed ID: 1405725)
1. Chronic myelocytic leukemia with myeloblastoma has higher frequency of ras oncogene mutation.
Tanaka K; Takauchi K; Takechi M; Dohy H; Kamada N
Leuk Res; 1992 Sep; 16(9):947. PubMed ID: 1405725
[No Abstract] [Full Text] [Related]
2. High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.
Tanaka K; Takauchi K; Takechi M; Kyo T; Dohy H; Kamada N
Leuk Lymphoma; 1994 Apr; 13(3-4):317-22. PubMed ID: 8049652
[TBL] [Abstract][Full Text] [Related]
3. [Progress on the study of related genes in patients with blast crisis of chronic myelocytic leukemia].
Xiong H; Chen X
Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):49-51. PubMed ID: 11498844
[No Abstract] [Full Text] [Related]
4. Blast crisis accompanied with occurrence of the point-mutational activation of N-ras proto-oncogene and the chromosomal abnormality inv(3q) in chronic myelogenous leukemia presenting thrombocytosis.
Okabe M; Kunieda Y; Saiki I; Shikano T; Kakinuma M; Miyazaki T
Leukemia; 1990 May; 4(5):381-2. PubMed ID: 2201830
[No Abstract] [Full Text] [Related]
5. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
[TBL] [Abstract][Full Text] [Related]
6. p53 gene mutation in the chronic phase was not detected in the myeloid crisis of a chronic myelocytic leukemia case.
Kurosawa M; Okabe M; Kunieda Y; Miyazaki T
Blood; 1994 May; 83(9):2750-2. PubMed ID: 8167355
[No Abstract] [Full Text] [Related]
7. [Deletion (7)(p11p15): an infrequent abnormality in blast crisis in chronic myeloid leukemia].
Resino M; Ferro MT; García-Laraña J; García-Sagredo JM; Cabello P; López-Yarto A; San Román C
Sangre (Barc); 1994 Dec; 39(6):465-7. PubMed ID: 7855700
[TBL] [Abstract][Full Text] [Related]
8. BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration.
Campbell LJ; Patsouris C; Rayeroux KC; Somana K; Januszewicz EH; Szer J
Cancer Genet Cytogenet; 2002 Nov; 139(1):30-3. PubMed ID: 12547154
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms in the evolution of chronic myelocytic leukemia.
Cline MJ; Jat PS; Foti A
Leuk Lymphoma; 1992 Jul; 7(4):283-7. PubMed ID: 1493427
[TBL] [Abstract][Full Text] [Related]
10. A t(20;21)(q12;q22.3) in a patient with chronic myelocytic leukemia in blastic phase.
Gozzetti A; Tozzuoli D; Crupi R; Gentili S; Raspadori D; Fabbri A; Lauria F
Cancer Genet Cytogenet; 2004 Apr; 150(1):90-1. PubMed ID: 15041233
[No Abstract] [Full Text] [Related]
11. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
12. Description of a new BCR-ABL point mutation in a CML patient with evolution to lymphoid blast crisis.
Hokama PO; Capannacci J; Hokama NK; Cliquet MG; Souza MP; Mauad MA; Colturato VA
Leuk Res; 2010 Apr; 34(4):e106-7. PubMed ID: 19931180
[No Abstract] [Full Text] [Related]
13. Absence of EZH2 gene mutation in chronic myeloid leukemia patients in blast crisis.
Chen HY; Yao H; Wu LY; Liu CJ; Zhu JQ; Liu CH; Wang W; Dong SS; Ping NN; Chen SN; Sun M
Asian Pac J Cancer Prev; 2013; 14(5):3375-6. PubMed ID: 23803132
[No Abstract] [Full Text] [Related]
14. Somatic mutations of PHF6 in patients with chronic myeloid leukemia in blast crisis.
Li X; Yao H; Chen Z; Wang Q; Zhao Y; Chen S
Leuk Lymphoma; 2013 Mar; 54(3):671-2. PubMed ID: 22928734
[No Abstract] [Full Text] [Related]
15. A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: a novel mechanism of p53 gene inactivation.
Foti A; Bar-Eli M; Ahuja HG; Cline MJ
Br J Haematol; 1990 Sep; 76(1):143-5. PubMed ID: 2223633
[TBL] [Abstract][Full Text] [Related]
16. A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases.
Grossmann V; Kohlmann A; Zenger M; Schindela S; Eder C; Weissmann S; Schnittger S; Kern W; Müller MC; Hochhaus A; Haferlach T; Haferlach C
Leukemia; 2011 Mar; 25(3):557-60. PubMed ID: 21274004
[No Abstract] [Full Text] [Related]
17. BCR rearrangements in Ph positive chronic myelocytic leukemia.
Deng DS; Yang AD; Gong WL; Fei HB; Liu SM
Chin Med J (Engl); 1991 Aug; 104(8):658-63. PubMed ID: 1680611
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.
Ahuja H; Bar-Eli M; Advani SH; Benchimol S; Cline MJ
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6783-7. PubMed ID: 2771957
[TBL] [Abstract][Full Text] [Related]
19. NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis.
Watkins DB; Hughes TP; White DL; D'Andrea RJ
Leukemia; 2013 Feb; 27(2):489-90. PubMed ID: 22791379
[No Abstract] [Full Text] [Related]
20. Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis.
Stagno F; Stella S; Berretta S; Massimino M; Antolino A; Giustolisi R; Messina A; Di Raimondo F; Vigneri P
Leuk Res; 2008 Apr; 32(4):673-4. PubMed ID: 17889935
[No Abstract] [Full Text] [Related]
[Next] [New Search]
